» Authors » Teresa K L Boitano

Teresa K L Boitano

Explore the profile of Teresa K L Boitano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 107
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Boitano T, Wall J, Bos L, Rocque G, Williams C, Smith H, et al.
Int J Gynecol Cancer . 2025 Feb; 35(2):100066. PMID: 39971447
Objective: The goal of this study was to evaluate the impact of a formalized research team and screening process on racial disparities associated with clinical trial enrollment at a tertiary...
2.
3.
Boitano T, Blank S, Havrilesky L, Huh W, Myers E
Gynecol Oncol . 2024 Nov; 191:287-291. PMID: 39488865
Objective: To estimate the effect of growth in gynecologic oncology fellowships in the United States on surgical volume for trainees and practicing gynecologic oncologists over the next 20 years. Methods:...
4.
Ketch P, Dowdy S, McBane 2nd R, Straughn Jr J, Boitano T
Gynecol Oncol Rep . 2024 Oct; 56:101508. PMID: 39391705
Venous thromboembolism (VTE) is a common cause of morbidity and mortality in gynecologic oncology patients with an increased risk in the postoperative period. Historically, international guidelines have recommended 28 days...
5.
Boitano T, Virk A, Straughn Jr J, Dowdy S
Gynecol Oncol Rep . 2024 Apr; 53:101389. PMID: 38623269
Surgical site infections (SSI) are one of the most common gynecologic oncology postoperative complications and they have a significant deleterious impact on the healthcare system and in patients' outcomes. Cefazolin...
6.
Kincaid K, Boitano T, Scalise M, Patton S, Leath 3rd C, Straughn Jr J, et al.
Gynecol Oncol Rep . 2024 Feb; 52:101344. PMID: 38404909
Objective: We aimed to assess the impact of preoperative steroid administration and perioperative glycemic control on postoperative complications in diabetic gynecologic oncology patients undergoing laparotomy. Methods: This retrospective cohort study...
7.
Boitano T, Kako T, Leath 3rd C
Obstet Gynecol . 2023 Oct; 142(6):1322-1332. PMID: 37826852
Despite effective screening strategies and the development and implementation of prophylactic high-risk human papillomavirus vaccination, cervical cancer remains a significant public health burden. This burden is most pronounced in under-resourced...
8.
Boitano T, Gardner A, Chu D, Leath 3rd C, Straughn Jr J, Smith H
Gynecol Oncol . 2023 Sep; 178:23-26. PMID: 37742507
Objective: To evaluate the impact of a mobile health patient engagement technology (PET) on postoperative outcomes in gynecologic oncology patients. Methods: All gynecologic oncology patients undergoing laparotomy on an enhanced...
9.
10.
Boitano T, Ketch P, Scarinci I, Huh W
Obstet Gynecol . 2023 Jan; 141(2):324-330. PMID: 36649341
Cervical cancer remains a significant disease in the United States. Although the human papillomavirus (HPV) vaccine has been approved for those aged 9-26 years and for some individuals up to...